May 2 (Reuters) - VBI Vaccines Inc VBIV.O -
* VBI Vaccines provides update on its congenital cmv phase i clinical study
* VBI Vaccines Inc - no safety signals have been detected, suggesting vbi's cmv vaccine candidate is safe and well-tolerated
* VBI Vaccines Inc - an interim safety and immunogenicity report, is expected mid-year 2017 Source text for Eikon: ID:nCCN1Q4D0T Further company coverage: VBIV.O